Shares Of Epizyme Of Cambridge Skyrocket 80%, After Pair Of Positive Developments

January 7, 2014 11:38 PM
Shares Of Epizyme Of Cambridge Skyrocket 80%, After Pair Of Positive Developments
" BOSTON (CBS) – Epizyme stock soared on Tuesday, after the company announced two important payments from its partners in the development of new types of cancer drugs.

These therapeutics are based on the human genome, according to Epizyme CEO Robert Gould.

“Understanding the DNA composition of cancer cells would enable one to target very particular cancer cells, so that a particular genetic alteration that was causing those cells to grow abnormally,” Gould says "

Click here to read the whole article

Google related News

Tuesday, January 07, 2014 by Motley Fool

Why Epizyme Inc. Shares Exploded Higher

What: Shares of Epizyme (NASDAQ: EPZM ) , a clinical-stage biopharmaceutical company developing treatments for patients with genetically 

Read more
Tuesday, January 07, 2014 by Motley Fool

Why Epizyme, Neurocrine Biosciences, and Peregrine Soared

Shares of the developmental stage cancer company Epizyme went ballistic in afterhours trading yesterday, rising over 34% on heavy volume, 

Read more
Tuesday, January 07, 2014 by 4-traders (press release)

Epizyme Inc : Ahead of the Bell: Epizyme shares jump

Epizyme will book a $25 million payment after a potential leukemia treatment reached an early milestone, sending company shares rocketing 

Read more
Wednesday, December 31, 1969 by Zolmax

Insider Selling: Jason Rhodes Unloads 10000 Shares of Epizyme ...

Epizyme logo Epizyme (NASDAQ:EPZM) CFO Jason Rhodes unloaded 10,000 shares of the company's stock in a transaction dated Monday, 

Read more